<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Acute Respiratory Distress Syndrome (ARDS) - Comprehensive Resource</title>
    <link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/font-awesome/6.4.0/css/all.min.css">
    <style>
        :root {
            --primary: #2c3e50;
            --secondary: #3498db;
            --accent: #e74c3c;
            --light: #ecf0f1;
            --dark: #2c3e50;
            --success: #27ae60;
            --warning: #f39c12;
        }
        
        * {
            margin: 0;
            padding: 0;
            box-sizing: border-box;
            font-family: 'Segoe UI', Tahoma, Geneva, Verdana, sans-serif;
        }
        
        body {
            background-color: #f8f9fa;
            color: #333;
            line-height: 1.6;
        }
        
        .container {
            width: 90%;
            max-width: 1200px;
            margin: 0 auto;
            padding: 20px;
        }
        
        header {
            background: linear-gradient(135deg, var(--primary) 0%, var(--secondary) 100%);
            color: white;
            padding: 2rem 0;
            text-align: center;
            border-bottom: 5px solid var(--accent);
            margin-bottom: 2rem;
        }
        
        header h1 {
            font-size: 2.5rem;
            margin-bottom: 0.5rem;
        }
        
        header p {
            font-size: 1.2rem;
            opacity: 0.9;
        }
        
        .nav-container {
            background-color: white;
            box-shadow: 0 2px 10px rgba(0,0,0,0.1);
            position: sticky;
            top: 0;
            z-index: 100;
        }
        
        nav {
            display: flex;
            justify-content: center;
            padding: 1rem 0;
        }
        
        nav a {
            color: var(--dark);
            text-decoration: none;
            padding: 0.5rem 1rem;
            margin: 0 0.5rem;
            border-radius: 4px;
            transition: all 0.3s ease;
        }
        
        nav a:hover {
            background-color: var(--secondary);
            color: white;
        }
        
        .section {
            background-color: white;
            border-radius: 8px;
            padding: 2rem;
            margin-bottom: 2rem;
            box-shadow: 0 4px 6px rgba(0,0,0,0.1);
        }
        
        .section h2 {
            color: var(--primary);
            border-bottom: 2px solid var(--secondary);
            padding-bottom: 0.5rem;
            margin-bottom: 1.5rem;
            display: flex;
            align-items: center;
        }
        
        .section h2 i {
            margin-right: 10px;
            color: var(--secondary);
        }
        
        .card {
            border-left: 4px solid var(--secondary);
            padding: 1rem 1.5rem;
            margin-bottom: 1.5rem;
            background-color: #f8f9fa;
            border-radius: 0 4px 4px 0;
        }
        
        .card h3 {
            color: var(--primary);
            margin-bottom: 0.5rem;
        }
        
        .grid {
            display: grid;
            grid-template-columns: repeat(auto-fit, minmax(300px, 1fr));
            gap: 1.5rem;
            margin: 1.5rem 0;
        }
        
        .grid-item {
            background-color: #f8f9fa;
            padding: 1.5rem;
            border-radius: 8px;
            border-top: 4px solid var(--secondary);
        }
        
        table {
            width: 100%;
            border-collapse: collapse;
            margin: 1.5rem 0;
        }
        
        th, td {
            padding: 12px 15px;
            text-align: left;
            border-bottom: 1px solid #ddd;
        }
        
        th {
            background-color: var(--primary);
            color: white;
        }
        
        tr:nth-child(even) {
            background-color: #f2f2f2;
        }
        
        .btn {
            display: inline-block;
            background-color: var(--secondary);
            color: white;
            padding: 8px 16px;
            border-radius: 4px;
            text-decoration: none;
            font-weight: 500;
            transition: all 0.3s ease;
            margin-top: 10px;
        }
        
        .btn:hover {
            background-color: var(--primary);
            transform: translateY(-2px);
        }
        
        .timeline {
            position: relative;
            max-width: 100%;
            margin: 2rem 0;
        }
        
        .timeline::after {
            content: '';
            position: absolute;
            width: 6px;
            background-color: var(--secondary);
            top: 0;
            bottom: 0;
            left: 50%;
            margin-left: -3px;
        }
        
        .timeline-item {
            position: relative;
            width: 50%;
            padding: 10px 40px;
        }
        
        .timeline-item::after {
            content: '';
            position: absolute;
            width: 20px;
            height: 20px;
            background-color: white;
            border: 4px solid var(--secondary);
            border-radius: 50%;
            top: 15px;
            right: -13px;
            z-index: 1;
        }
        
        .left {
            left: 0;
        }
        
        .right {
            left: 50%;
        }
        
        .left::before {
            content: " ";
            height: 0;
            position: absolute;
            top: 22px;
            width: 0;
            z-index: 1;
            right: 30px;
            border: medium solid var(--secondary);
            border-width: 10px 0 10px 10px;
            border-color: transparent transparent transparent var(--secondary);
        }
        
        .right::before {
            content: " ";
            height: 0;
            position: absolute;
            top: 22px;
            width: 0;
            z-index: 1;
            left: 30px;
            border: medium solid var(--secondary);
            border-width: 10px 10px 10px 0;
            border-color: transparent var(--secondary) transparent transparent;
        }
        
        .right::after {
            left: -13px;
        }
        
        .timeline-content {
            padding: 20px;
            background-color: white;
            position: relative;
            border-radius: 6px;
            box-shadow: 0 2px 8px rgba(0,0,0,0.1);
            border-top: 4px solid var(--secondary);
        }
        
        .timeline-content h3 {
            margin-top: 0;
            color: var(--primary);
        }
        
        .resource-list {
            list-style-type: none;
        }
        
        .resource-list li {
            margin-bottom: 1rem;
            padding-left: 1.5rem;
            position: relative;
        }
        
        .resource-list li::before {
            content: "â€¢";
            color: var(--secondary);
            font-weight: bold;
            display: inline-block;
            width: 1em;
            margin-left: -1em;
            font-size: 1.2rem;
        }
        
        .resource-list a {
            color: var(--secondary);
            text-decoration: none;
            transition: all 0.3s ease;
        }
        
        .resource-list a:hover {
            color: var(--primary);
            text-decoration: underline;
        }
        
        footer {
            background-color: var(--primary);
            color: white;
            text-align: center;
            padding: 2rem 0;
            margin-top: 2rem;
        }
        
        @media screen and (max-width: 768px) {
            .timeline::after {
                left: 31px;
            }
            
            .timeline-item {
                width: 100%;
                padding-left: 70px;
                padding-right: 25px;
            }
            
            .timeline-item::before {
                left: 60px;
                border: medium solid var(--secondary);
                border-width: 10px 10px 10px 0;
                border-color: transparent var(--secondary) transparent transparent;
            }
            
            .left::after, .right::after {
                left: 15px;
            }
            
            .right {
                left: 0%;
            }
            
            nav {
                flex-wrap: wrap;
            }
            
            nav a {
                margin: 0.25rem;
                padding: 0.5rem;
            }
        }
    </style>
</head>
<body>
    <header>
        <div class="container">
            <h1>Acute Respiratory Distress Syndrome (ARDS)</h1>
            <p>Comprehensive Clinical Resource for Critical Care Professionals</p>
        </div>
    </header>
    
    <div class="nav-container">
        <nav class="container">
            <a href="#definition">Definition</a>
            <a href="#etiology">Etiology</a>
            <a href="#pathophysiology">Pathophysiology</a>
            <a href="#management">Management</a>
            <a href="#studies">Landmark Studies</a>
            <a href="#guidelines">Guidelines</a>
            <a href="#resources">Resources</a>
        </nav>
    </div>
    
    <main class="container">
        <section id="definition" class="section">
            <h2><i class="fas fa-book-medical"></i> Definition</h2>
            <div class="card">
                <p>Acute Respiratory Distress Syndrome (ARDS) is a form of non-cardiogenic respiratory failure characterized by <strong>acute onset hypoxemia</strong>, <strong>bilateral pulmonary infiltrates on imaging</strong>, and <strong>reduced lung compliance</strong>, not fully explained by cardiac failure or fluid overload.</p>
            </div>
            
            <h3>Berlin Definition (2012) Diagnostic Criteria:</h3>
            <div class="grid">
                <div class="grid-item">
                    <h4>Timing</h4>
                    <p>Within 1 week of known clinical insult or new/worsening respiratory symptoms</p>
                </div>
                <div class="grid-item">
                    <h4>Chest Imaging</h4>
                    <p>Bilateral opacities not fully explained by effusions, lobar/lung collapse, or nodules</p>
                </div>
                <div class="grid-item">
                    <h4>Origin of Edema</h4>
                    <p>Respiratory failure not fully explained by cardiac failure or fluid overload</p>
                </div>
            </div>
            
            <h3>Oxygenation Severity (with PEEP/CPAP â‰¥5 cmHâ‚‚O):</h3>
            <table>
                <thead>
                    <tr>
                        <th>Severity</th>
                        <th>PaOâ‚‚/FiOâ‚‚ Ratio</th>
                        <th>Mortality Rate</th>
                    </tr>
                </thead>
                <tbody>
                    <tr>
                        <td>Mild</td>
                        <td>200-300 mmHg</td>
                        <td>27%</td>
                    </tr>
                    <tr>
                        <td>Moderate</td>
                        <td>100-200 mmHg</td>
                        <td>32%</td>
                    </tr>
                    <tr>
                        <td>Severe</td>
                        <td>â‰¤100 mmHg</td>
                        <td>45%</td>
                    </tr>
                </tbody>
            </table>
        </section>
        
        <section id="etiology" class="section">
            <h2><i class="fas fa-disease"></i> Etiology & Epidemiology</h2>
            
            <div class="grid">
                <div class="grid-item">
                    <h3>Direct Lung Injury (Pulmonary)</h3>
                    <ul>
                        <li>Pneumonia (bacterial, viral, fungal)</li>
                        <li>Aspiration of gastric contents</li>
                        <li>Lung contusion</li>
                        <li>Inhalational injury</li>
                        <li>Drowning</li>
                    </ul>
                </div>
                
                <div class="grid-item">
                    <h3>Indirect Lung Injury (Extrapulmonary)</h3>
                    <ul>
                        <li>Sepsis (most common)</li>
                        <li>Severe trauma</li>
                        <li>Pancreatitis</li>
                        <li>Massive transfusion</li>
                        <li>Drug overdose</li>
                    </ul>
                </div>
            </div>
            
            <div class="card">
                <h3>Epidemiology</h3>
                <p>ARDS affects approximately <strong>10% of ICU patients</strong> and <strong>23% of mechanically ventilated patients</strong> globally. Mortality ranges from 30-45% depending on severity, with higher rates in older patients and those with comorbidities. Many survivors experience long-term physical and neurocognitive impairment.</p>
            </div>
        </section>
        
        <section id="pathophysiology" class="section">
            <h2><i class="fas fa-lungs"></i> Pathophysiology</h2>
            
            <div class="card">
                <p>ARDS is characterized by <strong>alveolar-capillary barrier injury</strong> leading to protein-rich pulmonary edema, reduced lung compliance, ventilation-perfusion mismatch, and severe hypoxemia.</p>
            </div>
            
            <h3>Pathophysiological Phases:</h3>
            <div class="grid">
                <div class="grid-item">
                    <h4>Exudative Phase (0-7 days)</h4>
                    <p>Alveolar edema, inflammatory cell infiltration, hyaline membrane formation, and loss of surfactant function</p>
                </div>
                
                <div class="grid-item">
                    <h4>Proliferative Phase (7-21 days)</h4>
                    <p>Resolution of edema, fibroblast proliferation, and early lung repair</p>
                </div>
                
                <div class="grid-item">
                    <h4>Fibrotic Phase (>21 days)</h4>
                    <p>Collagen deposition and fibrosis in some patients, leading to long-term functional impairment</p>
                </div>
            </div>
            
            <h3>Key Pathophysiological Mechanisms:</h3>
            <ul>
                <li>Dysregulated inflammatory response (TNF, IL-1, IL-6, IL-8)</li>
                <li>Surfactant dysfunction leading to alveolar collapse</li>
                <li>Microvascular thrombosis and endothelial injury</li>
                <li>Activation of coagulation and impairment of fibrinolysis</li>
            </ul>
        </section>
        
        <section id="management" class="section">
            <h2><i class="fas fa-stethoscope"></i> Clinical Management</h2>
            
            <div class="card">
                <h3>General Principles</h3>
                <ul>
                    <li>Treat underlying cause (sepsis, pneumonia, trauma, etc.)</li>
                    <li>Supportive care with lung-protective strategies</li>
                    <li>Avoid iatrogenic harm (barotrauma, volutrauma, fluid overload)</li>
                    <li>Multidisciplinary approach with early involvement of intensivists</li>
                </ul>
            </div>
            
            <h3>Ventilatory Management</h3>
            <div class="grid">
                <div class="grid-item">
                    <h4>Lung-Protective Ventilation</h4>
                    <ul>
                        <li>Tidal volume: 6 mL/kg predicted body weight</li>
                        <li>Plateau pressure: â‰¤30 cmHâ‚‚O</li>
                        <li>Driving pressure: <15 cmHâ‚‚O</li>
                    </ul>
                </div>
                
                <div class="grid-item">
                    <h4>PEEP Strategies</h4>
                    <ul>
                        <li>Use moderate-to-high PEEP in moderate-severe ARDS</li>
                        <li>Balance recruitment vs overdistension</li>
                        <li>Consider PEEP/FiOâ‚‚ tables or esophageal manometry</li>
                    </ul>
                </div>
                
                <div class="grid-item">
                    <h4>Adjunctive Strategies</h4>
                    <ul>
                        <li>Prone positioning for severe ARDS (PaOâ‚‚/FiOâ‚‚ <150 mmHg)</li>
                        <li>Short-course neuromuscular blockade (â‰¤48h) in early severe ARDS</li>
                        <li>Conservative fluid management</li>
                    </ul>
                </div>
            </div>
            
            <h3>Rescue Therapies for Refractory Hypoxemia</h3>
            <table>
                <thead>
                    <tr>
                        <th>Therapy</th>
                        <th>Indication</th>
                        <th>Considerations</th>
                    </tr>
                </thead>
                <tbody>
                    <tr>
                        <td>ECMO</td>
                        <td>Severe ARDS with PaOâ‚‚/FiOâ‚‚ <80 despite optimal care</td>
                        <td>Resource-intensive, requires expertise</td>
                    </tr>
                    <tr>
                        <td>Inhaled Pulmonary Vasodilators</td>
                        <td>Refractory hypoxemia as bridge to recovery</td>
                        <td>Transient effect, may improve oxygenation</td>
                    </tr>
                    <tr>
                        <td>Recruitment Maneuvers</td>
                        <td>Severe hypoxemia with recruitable lung</td>
                        <td>Potential for hemodynamic compromise</td>
                    </tr>
                </tbody>
            </table>
        </section>
        
        <section id="studies" class="section">
            <h2><i class="fas fa-book-open"></i> Landmark ARDS Trials</h2>
            
            <div class="timeline">
                <div class="timeline-item left">
                    <div class="timeline-content">
                        <h3>ARDSNet ARMA (2000)</h3>
                        <p><strong>Intervention:</strong> Low tidal volume ventilation (6 mL/kg PBW)</p>
                        <p><strong>Finding:</strong> Reduced 28-day mortality and more ventilator-free days</p>
                        <a href="https://www.nejm.org/doi/full/10.1056/NEJM200005043421801" class="btn" target="_blank">Read Study</a>
                    </div>
                </div>
                <div class="timeline-item right">
                    <div class="timeline-content">
                        <h3>ALVEOLI (2004)</h3>
                        <p><strong>Intervention:</strong> Higher vs Lower PEEP</p>
                        <p><strong>Finding:</strong> Improved oxygenation but no mortality difference</p>
                        <a href="https://www.nejm.org/doi/full/10.1056/NEJMoa032193" class="btn" target="_blank">Read Study</a>
                    </div>
                </div>
                <div class="timeline-item left">
                    <div class="timeline-content">
                        <h3>FACTT (2006)</h3>
                        <p><strong>Intervention:</strong> Conservative vs liberal fluid strategy</p>
                        <p><strong>Finding:</strong> Conservative strategy increased ventilator-free days</p>
                        <a href="https://www.nejm.org/doi/full/10.1056/NEJMoa062200" class="btn" target="_blank">Read Study</a>
                    </div>
                </div>
                <div class="timeline-item right">
                    <div class="timeline-content">
                        <h3>CESAR (2009)</h3>
                        <p><strong>Intervention:</strong> Referral for ECMO vs conventional care</p>
                        <p><strong>Finding:</strong> Improved survival without severe disability</p>
                        <a href="https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(09)61069-2/fulltext" class="btn" target="_blank">Read Study</a>
                    </div>
                </div>
                <div class="timeline-item left">
                    <div class="timeline-content">
                        <h3>ACURASYS (2010)</h3>
                        <p><strong>Intervention:</strong> Early neuromuscular blockade (cisatracurium)</p>
                        <p><strong>Finding:</strong> Improved adjusted 90-day survival</p>
                        <a href="https://www.nejm.org/doi/full/10.1056/NEJMoa1005372" class="btn" target="_blank">Read Study</a>
                    </div>
                </div>
                <div class="timeline-item right">
                    <div class="timeline-content">
                        <h3>PROSEVA (2013)</h3>
                        <p><strong>Intervention:</strong> Early prolonged prone positioning</p>
                        <p><strong>Finding:</strong> Significant mortality reduction at 28 and 90 days</p>
                        <a href="https://www.nejm.org/doi/full/10.1056/NEJMoa1214103" class="btn" target="_blank">Read Study</a>
                    </div>
                </div>
                <div class="timeline-item left">
                    <div class="timeline-content">
                        <h3>Amato et al. (2015)</h3>
                        <p><strong>Intervention:</strong> Driving pressure focus</p>
                        <p><strong>Finding:</strong> Driving pressure most strongly associated with survival</p>
                        <a href="https://www.nejm.org/doi/full/10.1056/NEJMsa1410639" class="btn" target="_blank">Read Study</a>
                    </div>
                </div>
                <div class="timeline-item right">
                    <div class="timeline-content">
                        <h3>EOLIA (2018)</h3>
                        <p><strong>Intervention:</strong> Early ECMO vs conventional care</p>
                        <p><strong>Finding:</strong> No significant mortality reduction in primary analysis</p>
                        <a href="https://www.nejm.org/doi/full/10.1056/NEJMoa1800385" class="btn" target="_blank">Read Study</a>
                    </div>
                </div>
                <div class="timeline-item left">
                    <div class="timeline-content">
                        <h3>ROSE (2019)</h3>
                        <p><strong>Intervention:</strong> Early neuromuscular blockade vs usual care</p>
                        <p><strong>Finding:</strong> No mortality benefit; routine use not supported</p>
                        <a href="https://www.nejm.org/doi/full/10.1056/NEJMoa1901686" class="btn" target="_blank">Read Study</a>
                    </div>
                </div>
                <div class="timeline-item right">
                    <div class="timeline-content">
                        <h3>DEXA-ARDS (2020)</h3>
                        <p><strong>Intervention:</strong> Dexamethasone in moderate-severe ARDS</p>
                        <p><strong>Finding:</strong> Reduced duration of ventilation and 60-day mortality</p>
                        <a href="https://www.thelancet.com/journals/lanres/article/PIIS2213-2600(19)30417-5/fulltext" class="btn" target="_blank">Read Study</a>
                    </div>
                </div>
            </div>
        </section>
        
        <section id="guidelines" class="section">
            <h2><i class="fas fa-clipboard-list"></i> Current Guidelines & Recommendations</h2>
            
            <div class="card">
                <h3>ATS/ESICM/SCCM Guidelines (2017, updated 2022)</h3>
                <p>Strong recommendations for evidence-based management of ARDS patients.</p>
            </div>
            
            <table>
                <thead>
                    <tr>
                        <th>Recommendation</th>
                        <th>Strength</th>
                        <th>Evidence Level</th>
                    </tr>
                </thead>
                <tbody>
                    <tr>
                        <td>Low tidal volume ventilation (6 mL/kg PBW)</td>
                        <td>Strong</td>
                        <td>High</td>
                    </tr>
                    <tr>
                        <td>Plateau pressure â‰¤30 cmHâ‚‚O</td>
                        <td>Strong</td>
                        <td>High</td>
                    </tr>
                    <tr>
                        <td>Prone positioning in severe ARDS</td>
                        <td>Strong</td>
                        <td>High</td>
                    </tr>
                    <tr>
                        <td>Conservative fluid management</td>
                        <td>Conditional</td>
                        <td>Moderate</td>
                    </tr>
                    <tr>
                        <td>Short-course NMBA in early severe ARDS</td>
                        <td>Conditional</td>
                        <td>Moderate</td>
                    </tr>
                    <tr>
                        <td>ECMO in refractory hypoxemia</td>
                        <td>Conditional</td>
                        <td>Moderate</td>
                    </tr>
                </tbody>
            </table>
            
            <a href="https://www.atsjournals.org/doi/full/10.1164/rccm.201703-0548ST" class="btn" target="_blank">View Full Guidelines</a>
        </section>
        
        <section id="resources" class="section">
            <h2><i class="fas fa-external-link-alt"></i> Additional Resources</h2>
            
            <div class="card">
                <h3>For Further Enrichment</h3>
                <p>Explore these authoritative resources to deepen your understanding of ARDS management and research.</p>
            </div>
            
            <ul class="resource-list">
                <li><a href="https://www.uptodate.com/contents/acute-respiratory-distress-syndrome-ards-management-ventilation-strategies" target="_blank">UpToDate: ARDS Management</a> - Comprehensive clinical resource</li>
                <li><a href="https://journals.lww.com/ccmjournal/fulltext/2021/11000/Surviving_Sepsis_Campaign__International.21.aspx" target="_blank">Surviving Sepsis Campaign Guidelines</a> - Includes ARDS management in sepsis</li>
                <li><a href="https://www.esicm.org/" target="_blank">ESICM ARDS Section</a> - European Society of Intensive Care Medicine resources</li>
                <li><a href="http://www.ardsnet.org/" target="_blank">ARDSNet Protocols</a> - Research network and treatment protocols</li>
                <li><a href="https://www.ncbi.nlm.nih.gov/books/NBK436002/" target="_blank">NCBI Bookshelf: ARDS</a> - Detailed medical textbook chapter</li>
                <li><a href="https://www.thoracic.org/professionals/clinical-resources/critical-care/clinical-education/ards.php" target="_blank">ATS Patient Education</a> - American Thoracic Society resources</li>
            </ul>
        </section>
    </main>
    
    <footer>
        <div class="container">
            <p>Â© 2023 ARDS Resource | For Medical Professionals</p>
            <p>This resource is intended for educational purposes only. Always follow your institution's protocols and consult current guidelines when treating patients.</p>
        </div>
    </footer>
</body>
</html>